Biomarin Pharmaceuticals
(BMRN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 875,486 | 568,781 | 180,527 | 46,272 | 88,079 |
| Marketable Securities | 69,706 | 215,942 | 267,278 | 148,820 | 186,033 |
| Receivables | 144,472 | 117,822 | 109,066 | 104,839 | 86,576 |
| Inventories | 199,452 | 162,605 | 128,695 | 130,118 | 109,698 |
| Income taxes - deferred | N/A | 30,561 | 32,356 | 21,115 | N/A |
| Other current assets | 108,524 | 41,707 | 25,509 | 18,638 | 33,874 |
| TOTAL | $1,397,640 | $1,137,418 | $743,431 | $469,802 | $504,260 |
| Non-Current Assets | |||||
| PPE Net | 523,516 | 319,316 | 284,473 | 268,971 | 221,866 |
| Investments And Advances | 97,856 | 268,516 | 117,073 | 94,944 | 129,253 |
| Intangibles | 210,836 | 217,405 | 214,523 | 231,820 | 157,012 |
| Other Non-Current Assets | 245,531 | 301,405 | 208,847 | 240,172 | 250,232 |
| TOTAL | $1,077,739 | $1,106,642 | $824,916 | $835,907 | $758,363 |
| Total Assets | $2,475,379 | $2,244,060 | $1,568,347 | $1,305,709 | $1,262,623 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 23,365 | 0 | N/A |
| Accounts payable and accrued liabilities | 235,739 | 183,271 | 147,068 | 94,125 | 83,844 |
| TOTAL | $235,739 | $183,271 | $170,433 | $94,125 | $83,844 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 711,746 | 719,748 | 382,151 | 401,381 | 461,522 |
| TOTAL | $711,746 | $719,748 | $382,151 | $438,536 | $461,522 |
| Total Liabilities | $947,485 | $903,019 | $552,584 | $532,661 | $545,366 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 159,136 | 143,623 | 126,102 | 115,057 | 110,723 |
| Common Shares | 149 | 144 | 126 | 115 | 111 |
| Retained earnings | -849,770 | -715,801 | -539,448 | -425,101 | -371,265 |
| Other shareholders' equity | 17,771 | -2,403 | -6,805 | 952 | -1,777 |
| TOTAL | $1,527,894 | $1,341,041 | $1,015,763 | $773,048 | $717,257 |
| Total Liabilities And Equity | $2,475,379 | $2,244,060 | $1,568,347 | $1,305,709 | $1,262,623 |